Surveillance of survivors: Follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers

Gynecologic Oncology

Volumn 122, Issue 2, 2011, Pages 339-343

  Chapman, Jocelyn S ^a   Powell, C Bethan ^b   McLennan, Jane ^a   Crawford, Beth ^a   Mak, Julie ^a   Stewart, Nicola ^a   Chen, Lee May ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Bone density; BRCA1 2; CA125; Follow up; Risk reducing salpingo oophorectomy; Surgical menopause

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SURVIVOR; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PELVIC EXAMINATION; PERITONEUM CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCING SALPINGOOOPHORECTOMY; RISK REDUCTION; SALPINGOOOPHORECTOMY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BONE DENSITY; CA-125 ANTIGEN; ESTROGEN REPLACEMENT THERAPY; FALLOPIAN TUBES; FEMALE; FOLLOW-UP STUDIES; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; OVARIECTOMY; SURVIVORS;

EID: 79960452805     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.04.004     Document Type: Article

References (26)

1. Y. Miki, J. Swensen, and D. Shattuck-Eidens A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1 Science 266 1994 66 71 (Pubitemid 24345325)
2. R. Wooster, S.L. Neuhausen, and J. Mangion Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-130 Science 265 1994 2088 2090 (Pubitemid 24325690)
3. T.R. Rebbeck, H.T. Lynch, and S.L. Neuhausen Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 2002 1616 1622 (Pubitemid 34755669)
4. V.R. Grann, J.S. Jacobson, and D. Thomason Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis J Clin Oncol 20 2002 2520 2529 (Pubitemid 34525739)
5. H.D. Nelson, L.H. Huffman, R. Fu, and E.L. Harris Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force Ann Intern Med 143 2005 362 379
6. National Comprehensive Cancer Network NCCN clinical practice guidelines Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian. Version 1.2010. Fort Washington, PA: National Comprehensive Cancer Network 2010 Available online. Last accessed July 28, 2010
7. G.A. Colditz, W.C. Willett, and J.M. Stampfer Menopause and the risk of coronary heart disease in women N Engl J Med 316 1987 1105 1110 (Pubitemid 17052498)
8. T.M. Michelsen, A.H. Pripp, S. Tonstad, C.G. Tropé, and A. Dørum Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study Eur J Cancer 45 1 2009 Jan 82 89 Epub 2008 Nov 12
9. S.L. Shapiro, J. Manola, and M. Leboff Ovarian failure after djuvant chemotherapy is associated with rapid bone loss in women with early stage breast cancer J Clin Oncol 19 14 2001 3306 3311 (Pubitemid 32642182)
10. M.J. Casey, C. Synder, C. Bewtra, S.A. Narod, P. Watson, and H.T. Lynch Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations Gynecol Oncol 97 2 2005 May 457 467 (Pubitemid 40614890)
11. A. Finch, M. Beiner, and J. Lubinski Salpingo-oophorectomy and the risk of ovarian, fallopian tube and peritoneal cancers in women with BRCA 1 or BRCA2 mutation JAMA 296 2006 185 192
12. S.M. Domcheck, T.M. Friebel, and S.L. Neuhausen Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study Lancet Oncol 7 2006 223 229 (Pubitemid 43286452)
13. M.S. Beattie, B. Crawford, F. Lin, E. Vittinghoff, and J. Ziegler Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers Genet Test Mol Biomarkers 13 1 2009 Feb 51 56
14. K.A. Metcalfe, D. Birenbaum-Carmeli, J. Lubinski the Hereditary Breast Cancer Clinical Study Group International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers Int J Cancer 122 2008 2017 2022 (Pubitemid 351441190)
15. K.M. Schmeler, C.C. Sun, and D.C. Bodurka Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations Obstet Gynecol 108 2006 515 520 (Pubitemid 44337090)
16. L. Parente, C. Uyehara, W. Larsen, B. Whitcomb, and J. Farley Long-term impact of the women's health initiative on HRT Arch Gynecol Obstet 277 3 2008 Mar 219 224 (Pubitemid 351239593)
17. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333 (Pubitemid 34761611)
18. T.R. Rebbeck, T. Friebel, and T. Wagner Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE study group J Clin Oncol 23 31 2005 Nov 1 7772 7774
19. A. Eisen, J. Lubinski, and J. Gronwald Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers J Natl Cancer Inst 100 19 2008 Oct 1 1361 1367
20. R.T. Chlebowski, and R.L. Prentice Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution J Natl Cancer Inst 100 19 2008 Oct 1 1341 1343
21. J.E. Garber, and A.R. Hartman Prophylactic oophorectomy and hormone replacement therapy: protection at what price? J Clin Oncol 22 6 2004 Mar 15 978 980 (Pubitemid 41095027)
22. R. Lee, M. Beattie, and B. Crawford Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital Genet Test 9 2005 306 312 (Pubitemid 43099623)
23. Society of Gynecologic Oncologists Clinical Practice Committee statement on prophylactic salpingo-oophorectomy Gynecol Oncol 98 2005 179 181
24. F.W. Freeman, M.D. Sammel, I. Liu, and P. Martin Psychometric properties of a menopausal symptom list Menopause: The Journal of the North American Menopause Society 1 3 2003 258 265 (Pubitemid 36706312)
25. World Health Organization Scientific Group on the Prevention and Management of Osteoporosis Prevention and management of osteoporosis: report of a WHO scientific group WHO technical report series 2000 921 Geneva, Switzerland
26. S.R. Lakhani, M.J. Van De Vijver, and J. Jacquemier The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 9 2002 May 1 2310 2318 (Pubitemid 34441658)